血清异常凝血酶原检测在原发性肝癌诊断中的应用研究

Application research of serum abnormal prothrombin in the diagnosis of primary liver cancer

目的:探究血清异常凝血酶原检测在原发性肝癌诊断中的应用情况。方法:肝癌患者120例中,原发性肝癌60例作为A组,非原发性肝癌患者60例作为B组。比较两组血清异常凝血酶原、AFP水平。结果:A组AFP和血清异常凝血酶原显著高于B组,差异具有统计学意义(P<0.05)。血清异常凝血酶原诊断原发性肝癌准确率高于AFP,差异具有统计学意义(P<0.05)。结论:血清异常凝血酶原的检测能够应用于原发性肝癌患者的临床诊断,原发性肝癌患者的血清异常凝血酶原水平明显更高。

Objective:To explore the application of serum abnormal prothrombin in the diagnosis of primary liver cancer.Methods:Among120cases of patients with liver cancer,60cases of primary liver cancer were as the A group,and60cases of patients withnon-primary liver cancer were as the B group.The levels of serum abnormal prothrombin and AFP in the two groups werecompared.Results:The levels of AFP and serum abnormal prothrombin in the A group were significantly higher than those in the Bgroup,and the difference was statistically significant(P<0.05).The diagnostic accuracy of serum abnormal prothrombin forprimary liver cancer was higher than AFP,and the difference was statistically significant(P<0.05).Conclusion:The detection ofserum abnormal prothrombin could be used in the clinical diagnosis of patients with primary liver cancer,and the level of serumabnormal prothrombin in patients with primary liver cancer was significantly higher.